Ownership history in DB Fitzpatrick & Co, Inc · 17 quarters on record
This page tracks every 13F SEC filing in which DB Fitzpatrick & Co, Inc reported a position in Edwards Lifesciences Corp. (EW). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 17,956 | -181 | -1.0% | 1.36% | $1.5M | $85.25 |
| 2025 Q3 | REDUCED | 18,137 | -382 | -2.1% | 1.27% | $1.4M | $77.77 |
| 2025 Q2 | ADDED | 18,519 | +67 | +0.4% | 1.29% | $1.4M | $78.21 |
| 2025 Q1 | REDUCED | 18,452 | -2,082 | -10.1% | 1.27% | $1.3M | $72.48 |
| 2024 Q4 | REDUCED | 20,534 | -472 | -2.2% | 1.40% | $1.5M | $74.03 |
| 2024 Q3 | ADDED | 21,006 | +66 | +0.3% | 1.22% | $1.4M | $65.99 |
| 2024 Q2 | REDUCED | 20,940 | -154 | -0.7% | 1.79% | $1.9M | $92.37 |
| 2024 Q1 | ADDED | 21,094 | +57 | +0.3% | 1.85% | $2.0M | $95.56 |
| 2023 Q4 | ADDED | 21,037 | +3,213 | +18.0% | 1.54% | $1.6M | $76.25 |
| 2023 Q3 | ADDED | 17,824 | +67 | +0.4% | 1.32% | $1.2M | $69.28 |
As of 2025 Q4 — sorted by position size